View in EDS

Drug and country characteristics associated with global approval and launch of FDA-approved novel therapeutics.

Saved in:
Bibliographic Details
Title: Drug and country characteristics associated with global approval and launch of FDA-approved novel therapeutics.
Authors: Fu M; Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT), Yale School of Medicine, New Haven, CT 06520, United States.; Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06520, United States.; International Research Center for Medicinal Administration, Peking University, Beijing 100191, China., Wallach JD; Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT), Yale School of Medicine, New Haven, CT 06520, United States.; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA 30322, United States., So AD; Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT), Yale School of Medicine, New Haven, CT 06520, United States.; Innovation + Design Enabling Access (IDEA) Initiative, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, United States., Doernberg H; Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT), Yale School of Medicine, New Haven, CT 06520, United States.; Department of Internal Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, United States., Li X; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China., Guan X; International Research Center for Medicinal Administration, Peking University, Beijing 100191, China.; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China., Ramachandran R; Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT), Yale School of Medicine, New Haven, CT 06520, United States.; Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06520, United States.; Center for Outcomes Research and Evaluation, Yale-New Haven Health System, New Haven, CT 06510, United States., Ross JS; Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT), Yale School of Medicine, New Haven, CT 06520, United States.; Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06520, United States.; Center for Outcomes Research and Evaluation, Yale-New Haven Health System, New Haven, CT 06510, United States.; Department of Health Policy and Management, Yale School of Public Health, New Haven, CT 06520, United States.
Source: Health affairs scholar [Health Aff Sch] 2026 Jul 10; Vol. 4 (7), pp. qxag181. Date of Electronic Publication: 2026 Jul 10 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press on behalf of Project HOPE - The People-To-People Health Foundation, Inc Country of Publication: England NLM ID: 9918627882906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2976-5390 (Electronic) Linking ISSN: 29765390 NLM ISO Abbreviation: Health Aff Sch Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42482967
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Drug and country characteristics associated with global approval and launch of FDA-approved novel therapeutics.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Fu+M%22">Fu M</searchLink>; Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT), Yale School of Medicine, New Haven, CT 06520, United States.; Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06520, United States.; International Research Center for Medicinal Administration, Peking University, Beijing 100191, China.<br /><searchLink fieldCode="AU" term="%22Wallach+JD%22">Wallach JD</searchLink>; Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT), Yale School of Medicine, New Haven, CT 06520, United States.; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA 30322, United States.<br /><searchLink fieldCode="AU" term="%22So+AD%22">So AD</searchLink>; Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT), Yale School of Medicine, New Haven, CT 06520, United States.; Innovation + Design Enabling Access (IDEA) Initiative, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, United States.<br /><searchLink fieldCode="AU" term="%22Doernberg+H%22">Doernberg H</searchLink>; Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT), Yale School of Medicine, New Haven, CT 06520, United States.; Department of Internal Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, United States.<br /><searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.<br /><searchLink fieldCode="AU" term="%22Guan+X%22">Guan X</searchLink>; International Research Center for Medicinal Administration, Peking University, Beijing 100191, China.; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.<br /><searchLink fieldCode="AU" term="%22Ramachandran+R%22">Ramachandran R</searchLink>; Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT), Yale School of Medicine, New Haven, CT 06520, United States.; Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06520, United States.; Center for Outcomes Research and Evaluation, Yale-New Haven Health System, New Haven, CT 06510, United States.<br /><searchLink fieldCode="AU" term="%22Ross+JS%22">Ross JS</searchLink>; Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT), Yale School of Medicine, New Haven, CT 06520, United States.; Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06520, United States.; Center for Outcomes Research and Evaluation, Yale-New Haven Health System, New Haven, CT 06510, United States.; Department of Health Policy and Management, Yale School of Public Health, New Haven, CT 06520, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918627882906676%22">Health affairs scholar</searchLink> [Health Aff Sch] 2026 Jul 10; Vol. 4 (7), pp. qxag181. <i>Date of Electronic Publication: </i>2026 Jul 10 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press+on+behalf+of+Project+HOPE+-+The+People-To-People+Health+Foundation%2C+Inc%22">Oxford University Press on behalf of Project HOPE - The People-To-People Health Foundation, Inc </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9918627882906676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2976-5390 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2229765390%22">29765390 </searchLink><i>NLM ISO Abbreviation: </i>Health Aff Sch <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42482967
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/haschl/qxag181
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: qxag181
    Titles:
      – TitleFull: Drug and country characteristics associated with global approval and launch of FDA-approved novel therapeutics.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fu M
      – PersonEntity:
          Name:
            NameFull: Wallach JD
      – PersonEntity:
          Name:
            NameFull: So AD
      – PersonEntity:
          Name:
            NameFull: Doernberg H
      – PersonEntity:
          Name:
            NameFull: Li X
      – PersonEntity:
          Name:
            NameFull: Guan X
      – PersonEntity:
          Name:
            NameFull: Ramachandran R
      – PersonEntity:
          Name:
            NameFull: Ross JS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 07
              Text: 2026 Jul 10
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2976-5390
          Numbering:
            – Type: volume
              Value: 4
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Health affairs scholar
              Type: main
ResultId 1